Kidswell Bio Corporation

Pharmaceutical ・ 4584

Figures below come from this company's annual securities report (有価証券報告書) filed with Japan's Financial Services Agency. Filing a false statement is a criminal offence, which is what makes them worth building on.

Average annual pay
¥9.2m
filing entity, incl. bonuses
vs peers
+¥3.29m
same industry & average age
Average age
48.6 yrs
Average tenure
5.6 yrs
Employees
32
consolidated
Market cap
J-Quants, ~12-week delay
Working here from 22 to 60est. ¥277m grossindustry norm ¥200m ・ ¥205m after tax and social insurance (74%)
What is left after tax and social insurance? →How much did the 2026 changes move it? →

Corporate Number 5430001027036 (National Tax Agency)

Workforce disclosure

Japan requires listed companies to disclose these three ratios. They are useful but easy to misread — the notes matter.

ItemValue What it does not tell you
Female managersdefinition of 'manager' varies by company
Male parental leavecan exceed 100%; says nothing about duration
Gender pay gap (all workers)women's pay as % of men's; not equal-work comparison
Workplace score (beta)42.1deviation vs all listed, 50 = median
Investment score (beta)Nonedeviation vs all listed, 50 = median

Pay history

From past annual securities reports. Reorganisations move this figure even when pay itself does not — the average covers the filing entity only.

Fiscal year endAverage annual pay
2024-03-31¥7.5m
2025-03-31¥8.1m
2026-03-31¥9.2m

Similar companies

Same sector, closest by average pay. A starting point for comparison — not a ranking. Pay differences here are driven as much by average age and by how much of the group sits inside the filing entity as by how well a company pays.

Company Average payAvg ageCode
K Pharma,Inc.¥9.1m45.94896
TSUMURA & CO.¥9.1m41.94540
HEALIOS K.K.¥9.1m46.44593
Nippon Shinyaku Co.,Ltd.¥9.3m41.84516
株式会社サイフューズ¥9.4m42.84892
SAWAI GROUP HOLDINGS Co., Ltd.¥9.4m43.74887

Limitations

Source: annual securities report (EDINET, Financial Services Agency of Japan); market data from J-Quants (JPX Market Innovation & Research), ~12-week delay. Compiled independently by Corpus; not provided or endorsed by any government agency. Full detail in Japanese: キッズウェル・バイオ株式会社.